Novel therapies delay the progression of smoldering multiple myeloma: Case report and discussion.

about

Novel therapies delay the progression of smoldering multiple myeloma: Case report and discussion.

Item

http://www.wikidata.org/entity/Q39689809

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Novel therapies delay the prog ...... a: Case report and discussion.

@en

Novel therapies delay the prog ...... a: Case report and discussion.

@nl

type

Item

label

Novel therapies delay the prog ...... a: Case report and discussion.

@en

Novel therapies delay the prog ...... a: Case report and discussion.

@nl

prefLabel

Novel therapies delay the prog ...... a: Case report and discussion.

@en

Novel therapies delay the prog ...... a: Case report and discussion.

@nl

P1476

Novel therapies delay the prog ...... a: Case report and discussion.

@en

P2093

A Jhaveri

http://www.w3.org/2001/XMLSchema#string

P2860

Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease

Global cancer statistics, 2002

Solitary plasmacytoma of bone and asymptomatic multiple myeloma

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Thalidomide for previously untreated indolent or smoldering multiple myeloma.

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Antitumor activity of thalidomide in refractory multiple myeloma.

Bone marrow angiogenesis and progression in multiple myeloma.

P304

182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3332/ECANCER.2010.182

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Franco Muggia

P577

2010-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221776239

http://www.w3.org/2001/XMLSchema#string

P698

22276034

http://www.w3.org/2001/XMLSchema#string

P932

3234033

http://www.w3.org/2001/XMLSchema#string